The Supreme Court ruled unanimously in FDA v. Alliance for Hippocratic Medicine that physicians lack standing to contest the U.S. Food and Drug Administration's (FDA) decision to rescind safety guidelines pertaining to abortion pills. Justice Brett Kavanaugh acknowledged the plaintiffs' sincere legal, moral, ideological, and policy objections to elective abortion and the FDA's relaxed regulation of mifepristone, but noted that those objections are insufficient to demonstrate that doctors would suffer harm as a result of the FDA's actions.
The court also noted that it is possible for those who disagree with the abortion pill and its regulation to approach the Executive and Legislative Branches to seek stronger legislative or regulatory limitations on certain actions. The Fifth Circuit Court of Appeals concluded that the FDA had failed to address several important concerns when it relaxed limitations on the abortion medicine mifepristone after 2016.
The FDA's lax safety regulations have led to women being more likely to need medical care due to the FDA's lax safety regulations, which may lead to incomplete chemical abortions to address complications. The Alliance Defending Freedom expressed disappointment that the Court did not address the merits of the FDA's illegal actions, but stated that they will continue fighting for women's health and exposing the FDA's negligent practices and the dangers associated with abortion drugs.
The court also noted that it is possible for those who disagree with the abortion pill and its regulation to approach the Executive and Legislative Branches to seek stronger legislative or regulatory limitations on certain actions. The Fifth Circuit Court of Appeals concluded that the FDA had failed to address several important concerns when it relaxed limitations on the abortion medicine mifepristone after 2016.
The FDA's lax safety regulations have led to women being more likely to need medical care due to the FDA's lax safety regulations, which may lead to incomplete chemical abortions to address complications. The Alliance Defending Freedom expressed disappointment that the Court did not address the merits of the FDA's illegal actions, but stated that they will continue fighting for women's health and exposing the FDA's negligent practices and the dangers associated with abortion drugs.
